Daniel Donner


Accepting PhD Students

PhD projects

Biological Sex and Sex Hormone Modulation in Cardiovascular Disease, Immune System Modulation in Cardiac Arrest, Improving Rigour and Reproducibility in Preclinical Cardiology Research


Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Daniel (Dan) Donner is an Adjunct Senior Research Fellow at Monash University and University of Melbourne, and a Senior Research Officer at the Baker Institute (Discovery & Preclinical Domain). He also manages the Baker Institute’s Preclinical Cardiology Research Microsurgery and Imaging Platform, leading a team of senior research and technical staff and supervising Honours and PhD students. His research leadership is well supported by the Baker Institute and his postgraduate qualifications in research management (Sthrn Cross U) and leadership (Harvard U). 

As of March 2022, Dan has co-authored a total of 27 career papers (including in Circulation, Cardiovascular Research and Endocrinology). In 2018, he commenced a new research program addressing insufficiencies in preclinical cardiology research, leading to well-cited guidelines for echocardiography standardisation in mice (Donner et al, 2018, AJP-Hear & Circ). More recently, Dan’s independent program of industry-linked preclinical trials will soon see large bodies of extensive basic and translational work assembled for publication under his leadership.

Dan is an associate and special topics editor of Front Integrat Physiol, co-treasurer of the International Society for Heart Research (ISHR) ECI Committee, and member of the European Cardiology Society, and Endocrine Society. He was awarded the ISHR Early Career Investigator Prize (2019) and has received the Annual Baker Institute Values Awards for Responsible Use of Funds (2019); Research Integrity (2020); and Scientific Excellence (2021).

Since 2019, he has attracted >$900K in total research funding from the NHF (CI), Implicit Bioscience (PI/CIA), Servier (AI), UniMelb (AI), and various external awards/travel grants.

Research interests

  • The Impact of Biological Sex and Sex Hormones in Cardiovascular Disease and Injury
  • The Impact of Immune System Modulation in Cardiac Injury (Heart attack and cardiac arrest)
  • Preclinical Cardiology Research Rigour and Reproducibility for Improved Research Translation from Bench to Bedside

Supervision interests

  • PhD Students
  • Masters (by research) Students
  • Honours Students


  • Preclinical Cardiology Trial Design & Delivery
  • Preclinical Cardiology Translation Strategy
  • Myocardial Infarction Models
  • Cardiac Arrest Models
  • Heart Failure Models

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Certificate of Leadership, Harvard University

Award Date: 20 Dec 2020

Doctor of Philosophy (PhD), Selective Androgen Receptor Modulation in Androgen Decline and Obesity: Impact on the Heart, Metabolism and Bone, Griffith University

Award Date: 12 Nov 2015

Graduate Certificate in Research Management, Southern Cross University

Award Date: 13 Apr 2012

Master of Medical Research, Cardioprotection in Insulin Resistance and Obesity, Griffith University

Award Date: 13 Dec 2010

Bachelor of Biomedical Science, Griffith University

Award Date: 12 Dec 2008

External positions



Research area keywords

  • myocardial infarction
  • cardiac arrest
  • heart failure
  • heart attack
  • testosterone
  • estrogen
  • preclinical trials
  • industry research
  • sex hormones

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or